DOLOMITE EPPICC Study: Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir: Data from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) (208613)

07/03/2018
02/07/2024
EU PAS number:
EUPAS22915
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-208613-protocol-redact

English (598.86 KB - PDF) View document
Study results
Study results

Study Report DOLOMITE EPPIC_Pregnancy_Final Report Anonymized 03 Nov 2023

English (1.87 MB - PDF) View document
Study report
Other information